BME:GRFBiotechs
Grifols (BME:GRF) Valuation Check After Stronger Profitability In Full Year 2025 Results
Full year 2025 results put profitability in focus
Grifols (BME:GRF) has drawn fresh attention after reporting full year 2025 results, with sales of €7,524 million, net income of €402 million, and earnings per share from continuing operations of €0.59.
See our latest analysis for Grifols.
The earnings release and call on 26 February came against a weak backdrop for the shares, with a 1-day share price return of a 5.25% decline and a year-to-date share price return of a 10.92% decline, while...